Rocket Lab (RKLB) is trading lower as investors continue to digest and discount schedule risk around Neutron, the company’s next-generation medium-lift rocket that is central to the long-term growth narrative. Management updated the Neutron development schedule after a Stage 1 tank test failure, with the first launch now targeted for Q4 2026—pushing key catalyst timing further out and pressuring sentiment in a stock that has been pricing in aggressive growth. (investors.rocketlabcorp.com)

Neutron is viewed as the step-change product that expands Rocket Lab from dedicated small launches into higher-value missions and constellation deployment at larger scale. When high-growth names are valued on future milestones, even unchanged long-term demand can translate into near-term downside if the market starts to apply a bigger discount rate to those future cash flows or assigns a higher probability to additional slippage.

Rocket Lab has also delivered fundamental progress elsewhere, including record 2025 revenue and a record year-end backlog of $1.85 billion, which helps support visibility into 2026 execution even as Neutron’s debut shifts later. Still, for many traders the stock’s day-to-day direction remains highly sensitive to perceived probability of Neutron hitting schedule and moving from development milestones into flight demonstration. (investors.rocketlabcorp.com)